Natixis Investment Managers International Decreases Stake in Agilent Technologies, Inc. (NYSE:A)

Natixis Investment Managers International cut its position in shares of Agilent Technologies, Inc. (NYSE:A) by 20.7% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 3,877 shares of the medical research company’s stock after selling 1,011 shares during the quarter. Natixis Investment Managers International’s holdings in Agilent Technologies were worth $573,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently modified their holdings of A. JPMorgan Chase & Co. raised its holdings in Agilent Technologies by 97.6% during the second quarter. JPMorgan Chase & Co. now owns 2,758,655 shares of the medical research company’s stock worth $407,756,000 after purchasing an additional 1,362,425 shares during the last quarter. Winslow Capital Management LLC raised its holdings in shares of Agilent Technologies by 41.8% in the first quarter. Winslow Capital Management LLC now owns 2,783,552 shares of the medical research company’s stock worth $353,901,000 after acquiring an additional 820,171 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in shares of Agilent Technologies by 26.4% in the second quarter. Massachusetts Financial Services Co. MA now owns 3,922,079 shares of the medical research company’s stock worth $579,722,000 after acquiring an additional 818,615 shares during the last quarter. BlackRock Inc. raised its holdings in shares of Agilent Technologies by 2.3% in the second quarter. BlackRock Inc. now owns 25,652,287 shares of the medical research company’s stock worth $3,791,666,000 after acquiring an additional 574,202 shares during the last quarter. Finally, Man Group plc raised its holdings in shares of Agilent Technologies by 1,023.0% in the first quarter. Man Group plc now owns 585,983 shares of the medical research company’s stock worth $74,502,000 after acquiring an additional 533,805 shares during the last quarter.

Shares of NYSE:A traded up $2.01 during trading on Thursday, hitting $152.23. The company’s stock had a trading volume of 775 shares, compared to its average volume of 1,652,275. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.63 and a current ratio of 2.11. Agilent Technologies, Inc. has a fifty-two week low of $100.65 and a fifty-two week high of $179.57. The stock’s 50-day moving average price is $165.93 and its two-hundred day moving average price is $148.87. The company has a market capitalization of $46.08 billion, a PE ratio of 46.94, a PEG ratio of 3.17 and a beta of 1.00.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, August 16th. The medical research company reported $1.10 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.99 by $0.11. Agilent Technologies had a return on equity of 26.12% and a net margin of 16.12%. The business had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.54 billion. During the same quarter in the previous year, the firm posted $0.78 earnings per share. The company’s revenue was up 25.8% compared to the same quarter last year. On average, equities analysts predict that Agilent Technologies, Inc. will post 4.31 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 27th. Investors of record on Tuesday, October 5th will be paid a $0.194 dividend. This represents a $0.78 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Monday, October 4th. Agilent Technologies’s dividend payout ratio (DPR) is 23.78%.

A number of equities analysts have recently weighed in on the company. Stifel Nicolaus boosted their price target on Agilent Technologies from $136.00 to $162.00 and gave the stock a “hold” rating in a report on Wednesday, August 18th. Cowen boosted their price target on Agilent Technologies from $165.00 to $200.00 and gave the stock an “outperform” rating in a report on Friday, September 17th. They noted that the move was a valuation call. Citigroup lifted their price objective on Agilent Technologies from $160.00 to $190.00 and gave the company a “buy” rating in a research report on Wednesday, August 18th. Robert W. Baird lifted their price objective on Agilent Technologies from $144.00 to $170.00 and gave the company an “outperform” rating in a research report on Wednesday, August 18th. Finally, Societe Generale raised Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Tuesday, June 22nd. One equities research analyst has rated the stock with a hold rating and twenty-two have given a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Buy” and an average price target of $141.82.

In other Agilent Technologies news, SVP Dominique Grau sold 9,033 shares of the company’s stock in a transaction that occurred on Wednesday, August 18th. The stock was sold at an average price of $165.06, for a total transaction of $1,490,986.98. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Agilent Technologies Company Profile

Agilent Technologies, Inc engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets; Diagnostics and Genomics; and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.

Featured Story: Nikkei 225 Index

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.